Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ivona Risović"'
The Predictive Role of Leptin in Malnutrition-Inflammation Complex Syndrome in Hemodialysis Patients
Autor:
Ivona Risović, Vlastimir Vlatković, Snježana Popović Pejičić, Jasna Trbojević Stanković, Gabrijela Malešević
Publikováno v:
Acta Clinica Croatica, Vol 62., Iss 4, Pp 644-651 (2023)
Leptin is a protein hormone secreted by adipocytes. Its role in malnutrition-inflammation complex syndrome (MICS) in hemodialysis (HD) patients has not been fully resolved yet. We aimed to assess the predictive role of serum leptin in MICS in maint
Externí odkaz:
https://doaj.org/article/ba9ca5e1c79d436187660f48b9b59fe5
Publikováno v:
Биомедицинска истраживања. 8:97-104
Uvod. Kardiovaskularne bolesti (KVB) su glavni uzrok smrti kod oboljelihod diabetes mellitus-a (DM). Danas se smatra da je tip 2 DM ekvivalent koronarnebolesti, te se preporučuje intenzivna kontrola svih faktora rizika zanastanak KVB kod oboljelih o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c04841565eeaf9e92a40c2a67fc50404
https://doi.org/10.7251/bii1702097v
https://doi.org/10.7251/bii1702097v
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 23(1)
Maintenance hemodialysis (HD) patients often experience fluctuations of volume status. Although hypervolemia possibly induces systemic inflammation, the relationship between volume status and leptin has not yet been well defined. The aims of this stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::17cb23173f351344351854c0d144fc18
https://pubmed.ncbi.nlm.nih.gov/30225886
https://pubmed.ncbi.nlm.nih.gov/30225886
Publikováno v:
BMC Endocrine Disorders, Vol 23, Iss 1, Pp 1-6 (2023)
Abstract Background Two types of fixed-ratio combinations of basal insulin and a glucagon-like peptide-1 receptor agonist (GLP-1RA) have been approved for use in type 2 diabetes. One is insulin degludec/liraglutide (iDergLira), and the other is insul
Externí odkaz:
https://doaj.org/article/7474c63a60414f3fa56c00aa4c44e688
Autor:
Ivona Risović, Aleksandar Arežina
Publikováno v:
Scripta Medica. 40:51-55
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b6be894e4a6de855f0fc93090028d55
https://doi.org/10.5937/scrimed0901051x
https://doi.org/10.5937/scrimed0901051x